BioSpace News Archive

Biotech Bay

RenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy Platform

RenovoRx, Inc. announced today that the Company has filed an international patent application under the Patent Cooperation Treaty (PCT) for its novel Trans-Arterial Micro-Perfusion (TAMP) therapy platform.

December 13, 2023
·
8 min read
FDA Breakthrough Device using Optical Spectroscopy was Found to Significantly Increase Physicians’ Detection of Skin Cancer

DermaSensor Inc ., the pioneer of the first point-and-click skin cancer detection device for primary care physicians, announces the publication of a new study 1 in the Journal of Primary Care and Community Health.

December 13, 2023
·
4 min read
Drug Development

Ceapro Inc. Announces Dosing of First Patients in Phase 1-2a Study Assessing Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases

Ceapro Inc.(TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”) today announced the commencement of patient dosing in its Phase 1-2a study evaluating its flagship product, avenanthramides, for potential applications in managing conditions related to inflammation.

December 13, 2023
·
4 min read
Genetown

Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China’s National Reimbursement Drug List

Paratek Pharmaceuticals, Inc. today announced that China’s National Healthcare Security Administration (NHSA) has added the oral formulation of NUZYRA® (omadacycline) to the country’s National Reimbursement Drug List (NRDL) for treatment of community-acquired bacterial pneumonia.

December 13, 2023
·
2 min read
BioCapital

Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation Capecitabine

Processa Pharmaceuticals, Inc. announces the outcomes from a successful meeting with the U.S. Food and Drug Administration (“FDA”) regarding the Company’s next Phase 2 study supporting the advancement of Next Generation Capecitabine (“NGC-Cap”) for cancer patients.

December 13, 2023
·
4 min read
Business

Editas Medicine and Vertex Pharmaceuticals Enter into Non-exclusive License Agreement for Cas9

Editas Medicine, Inc. and Vertex Pharmaceuticals entered into a license agreement.

December 13, 2023
·
3 min read
Deals

Veranex Acquires Leading Preclinical Services Provider T3 Labs

Veranex today announced that it has acquired T3 Labs, a highly reputable preclinical laboratory located in Atlanta, Georgia.

December 13, 2023
·
3 min read
Immunocan Provides Update on Business Operations, Highlighting Launch of New Gene-edited Mice Generating Fully Human Heavy-chain-only Antibodies and Advances in Partner Pipeline

Shanghai Immunocan Biotech Co., Ltd. announces the launch of its ImmuMab Heavy® mice.

December 13, 2023
·
3 min read
Inovedis Announces First Patients Treated with the SINEFIX™ Rotator Cuff Repair System

Inovedis GmbH today announced that the first two patients were treated with the SINEFIX™ Rotator Cuff Repair System as part of a pre-market clinical study in Tübingen, Germany.

December 13, 2023
·
2 min read
Biotech Bay

Alveo Technologies Announces Major Distribution Expansion Across EMEA

Alveo Technologies, Inc., a leader in molecular sensing and diagnostics with its proprietary technology platform, announced 19 new distributor partnerships across Europe, Africa, and the Middle East.

December 13, 2023
·
3 min read